nach oben

Inflammopharmacology

Erschienen in:

18.07.2019 | Original Article

PD123319, angiotensin II type II receptor antagonist, inhibits oxidative stress and inflammation in 2, 4-dinitrobenzene sulfonic acid-induced colitis in rat and ameliorates colonic contractility

verfasst von: Maria Grazia Zizzo, Gaetano Caldara, Annalisa Bellanca, Domenico Nuzzo, Marta Di Carlo, Rosa Serio

Erschienen in: Inflammopharmacology | Ausgabe 1/2020

Einloggen, um Zugang zu erhalten

Abstract

Angiotensin II, the main effector of renin angiotensin system, plays an important role in the inflammatory process and most of its effects are mediated through the AT1 receptor activation. However, the knowledge about the AT2 receptor involvement in this process is still evolving. We previously found that in an experimental model of colitis, AT2 receptor activation can contribute to the impairment of the muscle contractility in vitro in the course of inflammation. Here, we investigated the potential alleviating effects of the in vivo treatment of PD123319 (1-[[4-(Dimethylamino)-3-methylphenyl]methyl]-5-(diphenylacetyl)-4,5,6,7- tetrahydro-1H-imidazo[4,5-c]pyridine-6-carboxylic acid ditrifluoroacetate), AT2 receptor antagonist, in 2,4-dinitrobenzene sulfonic acid (DNBS)-induced rat model of colitis. The effects of i.p PD123319 (0.3, 3 and 10 mg/kg) administration to rats subjected to intra-rectal DNBS instillation were investigated. The study revealed that the colon injury and the inflammatory signs were ameliorated by PD123319 when visualized by the histopathological examination. The colon shortening, myeloperoxidase activity, and colonic expression of IL-1β, IL-6 and iNOS were downregulated in a dose-dependent manner in DNBS-induced colitis rats treated with PD123319 and the anti-oxidant defense machinery was also improved. The mechanism of these beneficial effects was found in the ability of PD123319 to inhibit NF-κB activation induced by DNBS. The colonic contractility in inflamed tissues was also improved by PD123319 treatment. In conclusion, our data have demonstrated previously that undescribed proinflammatory effects for the AT2 receptors in DNBS-induced colitis in rats in which they are mediated likely by NF-κB activation and reactive oxygen species generation. Moreover, when the inflammatory process is mitigated by the AT2 receptor antagonist treatment, the smooth muscle is able to recover its functionality.

Akishita M, Horiuchi M, Yamada H, Zhang L, Shirakami G, Tamura K, Ouchi Y, Dzau VJ (2000) Inflammation influences vascular remodeling through AT2 receptor expression and signaling. Physiol Genomics 2:13–20PubMed

Altara R, Didion P, Booz GW (2016) Conflicting mechanisms of AT2 cardioprotection revealed. Cardiovasc Res 112(1):426–428PubMedPubMedCentral

Appleyard CB, Wallace JL (1995) Reactivation of hapten-induced colitis and its prevention by anti-inflammatory drugs. Am J Physiol 269:G119–G125PubMed

Arab HH, Al-Shorbagy MY, Abdallah DM, Nassar NN (2014) Telmisartan attenuates colon inflammation, oxidative perturbations and apoptosis in a rat model of experimental inflammatory bowel disease. PLoS One 9:e97193PubMedPubMedCentral

Bhattacharyya A, Chattopadhyay R, Mitra S, Crowe SE (2014) Oxidative stress: an essential factor in the pathogenesis of gastrointestinal mucosal diseases. Physiol Rev 94:329–354PubMedPubMedCentral

Buhrmann C, Mobasheri A, Busch F, Aldinger C, Stahlmann R, Montaseri A, Shakibaei M (2011) Curcumin modulates nuclear factor kappaB (NF-kappaB)-mediated inflammation in human tenocytes in vitro: role of the phosphatidylinositol 3-kinase/Akt pathway. J Biol Chem 286:28556–28566PubMedPubMedCentral

Carey RM (2017) Update on angiotensin AT2 receptors. Curr Opin Nephrol Hypertens 26:91–96PubMedPubMedCentral

Conner EM, Brand SJ, Davis JM, Kang DY, Grisham MB (1996) Role of reactive metabolites of oxygen and nitrogen in inflammatory bowel disease: toxins, mediators, and modulators of gene expression. Inflamm Bowel Dis 2:133–147PubMed

de Gasparo GM, Catt KJ, Inagami T, Wright JW, Unger T (2000) International union of pharmacology. XXIII. The angiotensin II receptors. Pharmacol Rev 52:415–472PubMed

Esteban V, Ruperez M, Vita JR, Lopez ES, Mezzano S, Plaza JJ, Egido J, Ruiz-Ortega M (2003) Effect of simultaneous blockade of AT1 and AT2 receptors on the NFkappaB pathway and renal inflammatory response. Kidney Int 64(Suppl):S33–S38

Esteban V, Lorenzo O, Ruperez M, Suzuki Y, Mezzano S, Blanco J, Kretzler M, Sugaya T, Egido J, Ruiz-Ortega M (2004) Angiotensin II, via AT1 and AT2 receptors and NF-kappaB pathway, regulates the inflammatory response in unilateral ureteral obstruction. J Am Soc Nephrol 15:1514–1529PubMed

Ewert S, Spak E, Olbers T, Johnsson E, Edebo A, Fandriks L (2006) Angiotensin II induced contraction of rat and human small intestinal wall musculature in vitro. Acta Physiol (Oxf) 188:33–40

Fandriks L (2011) The renin-angiotensin system and the gastrointestinal mucosa. Acta Physiol (Oxf) 201:157–167

Fishlock DJ, Gunn A (1970) The action of angiotensin on the human colon in vitro. Br J Pharmacol 39:34–39PubMedPubMedCentral

Gandhi AV, Chipitsyna G, Relles D, Yeo CJ, Arafat HA (2017) Angiotensin II type 2 receptor: a novel modulator of inflammation in pancreatic ductal adenocarcinoma through regulation of NF-kB activity. J Cancer Tumor Int 5:1–11. https://doi.org/10.9734/JCTI/2017/31326 CrossRef

Hirasawa K, Sato Y, Hosoda Y, Yamamoto T, Hanai H (2002) Immunohistochemical localization of angiotensin II receptor and local renin-angiotensin system in human colonic mucosa. J Histochem Cytochem 50:275–282PubMed

Horiuchi M (2016) The protective arm of renin angiotensin system; recent research progress and expectation for new therapeutic approach. Nihon Rinsho 74:1583–1589PubMed

Hume GE, Radford-Smith GL (2008) ACE inhibitors and angiotensin II receptor antagonists in Crohn’s disease management. Expert Rev Gastroenterol Hepatol 2:645–651PubMed

Hunter MM, Wang A, Hirota CL, McKay DM (2005) Neutralizing anti-IL-10 antibody blocks the protective effect of tapeworm infection in a murine model of chemically induced colitis. J Immunol 174:7368–7375PubMed

Ikeda I, Kasajima T, Ishiyama S, Shimojo T, Takeo Y, Nishikawa T, Kameoka S, Hiroe M, Mitsunaga A (1997) Distribution of inducible nitric oxide synthase in ulcerative colitis. Am J Gastroenterol 92:1339–1341PubMed

Inokuchi Y, Morohashi T, Kawana I, Nagashima Y, Kihara M, Umemura S (2005) Amelioration of 2,4,6-trinitrobenzene sulphonic acid induced colitis in angiotensinogen gene knockout mice. Gut 54:349–356PubMedPubMedCentral

Jaszewski R, Tolia V, Ehrinpreis MN, Bodzin JH, Peleman RR, Korlipara R, Weinstock JV (1990) Increased colonic mucosal angiotensin I and II concentrations in Crohn’s colitis. Gastroenterology 98:1543–1548PubMed

Kandhare AD, Raygude KS, Ghosh P, Ghule AE, Gosavi TP, Badole SL, Bodhankar SL (2012) Effect of hydroalcoholic extract of Hibiscus rosa sinensis Linn. leaves in experimental colitis in rats. Asian Pac J Trop Biomed 2:337–344PubMedPubMedCentral

Karnik SS, Unal H, Kemp JR, Tirupula KC, Eguchi S, Vanderheyden PM, Thomas WG (2015) International Union of Basic and Clinical Pharmacology. XCIX. Angiotensin receptors: interpreters of pathophysiological angiotensinergic stimuli (corrected). Pharmacol Rev 67:754–819PubMedPubMedCentral

Katada K, Yoshida N, Suzuki T, Okuda T, Mizushima K, Takagi T, Ichikawa H, Naito Y, Cepinskas G, Yoshikawa T (2008) Dextran sulfate sodium-induced acute colonic inflammation in angiotensin II type 1a receptor deficient mice. Inflamm Res 57:84–91PubMed

Kim S, Iwao H (2000) Molecular and cellular mechanisms of angiotensin II-mediated cardiovascular and renal diseases. Pharmacol Rev 52:11–34PubMed

Kimura H, Hokari R, Miura S, Shigematsu T, Hirokawa M, Akiba Y, Kurose I, Higuchi H, Fujimori H, Tsuzuki Y, Serizawa H, Ishiii H (1998) Increased expression of an inducible isoform of nitric oxide synthase and the formation of peroxynitrite in colonic mucosa of patients with active ulcerative colitis. Gut 42:180–187PubMedPubMedCentral

Klahr S, Morrissey JJ (2000) The role of vasoactive compounds, growth factors and cytokines in the progression of renal disease. Kidney Int 75(Suppl):S7–S14

Kolios G, Rooney N, Murphy CT, Robertson DAF, Westwick J (1998) Expression of inducible nitric oxide synthase activity in human colon epithelial cells: modulation by T-lymphocyte derived cytokines. Gut 43:56–63PubMedPubMedCentral

Lawrence T (2009) The nuclear factor NF-kappaB pathway in inflammation. Cold Spring Harb Perspect Biol 1:a001651PubMedPubMedCentral

Liu T, Zhang L, Joo D, Sun SC (2017) NF-kappaB signaling in inflammation. Signal Transduct Target Ther 2:17023PubMedPubMedCentral

Mastropaolo M, Zizzo MG, Mule F, Serio R (2013) Angiotensin II contractile effects in mouse colon: role for pre- and post-junctional AT(1A) receptors. Acta Physiol (Oxf) 207:337–345

Mastropaolo M, Zizzo MG, Auteri M, Caldara G, Liotta R, Mule F, Serio R (2015) Activation of angiotensin II type 1 receptors and contractile activity in human sigmoid colon in vitro. Acta Physiol (Oxf) 215:37–45

Matavelli LC, Huang J, Siragy HM (2011) Angiotensin AT(2) receptor stimulation inhibits early renal inflammation in renovascular hypertension. Hypertension 57:308–313PubMed

Matsubara H (1998) Pathophysiological role of angiotensin II type 2 receptor in cardiovascular and renal diseases. Circ Res 83:1182–1191PubMed

Menk M, Graw JA, von Haefen HC, Steinkraus H, Lachmann B, Spies CD, Schwaiberger D (2018) Angiotensin II type 2 receptor agonist compound 21 attenuates pulmonary inflammation in a model of acute lung injury. J Inflamm Res 11:169–178PubMedPubMedCentral

Middleton SJ, Shorthouse M, Hunter JO (1993) Relaxation of distal colonic circular smooth muscle by nitric oxide derived from human leukocytes. Gut 34:814–817PubMedPubMedCentral

Mizushima T, Sasaki M, Ando T, Wada T, Tanaka M, Okamoto Y, Ebi M, Hirata Y, Murakami K, Mizoshita T, Shimura T, Kubota E, Ogasawara N, Tanida S, Kataoka H, Kamiya T, Alexander JS, Joh T (2010) Blockage of angiotensin II type 1 receptor regulates TNF-alpha-induced MAdCAM-1 expression via inhibition of NF-kappaB translocation to the nucleus and ameliorates colitis. Am J Physiol Gastrointest Liver Physiol 298:G255–G266PubMed

Moreels TG, De Man JG et al (2001) Effect of Schistosoma mansoni-induced granulomatous inflammation on murine gastrointestinal motility. Am J Physiol Gastrointest Liver Physiol 280:G1030–G1042PubMed

Munoz MC, Burghi V, Miquet JG, Cervino IA, Quiroga DT, Mazziotta L, Dominici FP (2017) Chronic blockade of the AT2 receptor with PD123319 impairs insulin signaling in C57BL/6 mice. Peptides 88:37–45PubMed

Nakajima M, Hutchinson HG, Fujinaga M, Hayashida W, Morishita R, Zhang L, Horiuchi M, Pratt RE, Dzau VJ (1995) The angiotensin II type 2 (AT2) receptor antagonizes the growth effects of the AT1 receptor: gain-of-function study using gene transfer. Proc Natl Acad Sci USA 92:10663–10667PubMedPubMedCentral

Namsolleck P, Recarti C, Foulquier S, Steckelings UM, Unger T (2014) AT(2) receptor and tissue injury: therapeutic implications. Curr Hypertens Rep 16:416PubMedPubMedCentral

Ohshima H, Bartsch H (1994) Chronic infections and inflammatory processes as cancer risk factors: possible role of nitric oxide in carcinogenesis. Mutat Res 305:253–264PubMed

Perez S, Talens-Visconti R, Rius-Perez S, Finamor I, Sastre J (2017) Redox signaling in the gastrointestinal tract. Free Radic Biol Med 104:75–103PubMed

Pulli B, Ali M, Forghani R, Schob S, Hsieh KL, Wojtkiewicz G, Linnoila JJ, Chen JW (2013) Measuring myeloperoxidase activity in biological samples. PLoS One 8:e67976PubMedPubMedCentral

Rachmilewitz D, Stamler JS, Karmeli F, Mullins ME, Singel DJ, Loscalzo J, Xavier RJ, Podolsky DK (1993) Peroxynitrite-induced rat colitis–a new model of colonic inflammation. Gastroenterology 105:1681–1688PubMed

Ribbons KA, Zhang X-J, Thompson JH et al (1995) Potential role of nitric oxide in a model of chronic colitis in rhesus macaques. Gastroenterology 108:705–711PubMed

Ruiz-Ortega M, Lorenzo O, Ruperez M, Suzuki Y, Egido J (2001) Angiotensin II activates nuclear transcription factor-kappaB in aorta of normal rats and in vascular smooth muscle cells of AT1 knockout mice. Nephrol Dial Transplant 16(Suppl 1):27–33PubMed

Ruiz-Ortega M, Esteban V, Suzuki Y, Ruperez M, Mezzano S, Ardiles L, Justo P, Ortiz A, Egido J (2003) Renal expression of angiotensin type 2 (AT2) receptors during kidney damage. Kidney Int 64:S21–S26

Ruiz-Ortega M, Ruperez M, Esteban V, Rodriguez-Vita J, Sanchez-Lopez E, Carvajal G, Egido J (2006) Angiotensin II: a key factor in the inflammatory and fibrotic response in kidney diseases. Nephrol Dial Transplant 21:16–20PubMed

Salminen A, Huuskonen J, Ojala J, Kauppinen A, Kaarniranta K, Suuronen T (2008) Activation of innate immunity system during aging: NF-kB signaling is the molecular culprit of inflamm-aging. Ageing Res Rev 7:83–105PubMed

Sasaki M, Bharwani S, Jordan P, Elrod JW, Grisham MB, Jackson TH, Lefer DJ, Alexander JS (2003) Increased disease activity in eNOS-deficient mice in experimental colitis. Free Radic Biol Med. 35(12):1679–1687PubMed

Shi Y, Liu T, He L, Dougherty U, Chen L, Adhikari S, Alpert L, Zhou G, Liu W, Wang J, Deb DK, Hart J, Liu SQ, Kwon J, Pekow J, Rubin DT, Zhao Q, Bissonnette M, Li YC (2016) Activation of the renin-angiotensin system promotes colitis development. Sci Rep 6:27552PubMedPubMedCentral

Verdonk K, Durik M, Abd-Alla N, Batenburg WW, van den Bogaerdt AJ, van VR, Roks AJ, Danser AH, van Esch JH (2012) Compound 21 induces vasorelaxation via an endothelium- and angiotensin II type 2 receptor-independent mechanism. Hypertension 60:722–729PubMed

Vallance BA, Dijkstra G, Qiu B, van der Waaij LA, vanGoor H, Jansen PLM, Collins SM (2004) Relative contributions of NOS isoforms during experimental colitis: endothelial-derived NOS maintains mucosal integrity. Am J Physiol Gastrointest Liver Physiol 287(4):G865–G874PubMed

Zizzo MG, Auteri M, Amato A, Caldara G, Nuzzo D, Di CM, Serio R (2017) Angiotensin II type II receptors and colonic dysmotility in 2,4-dinitrofluorobenzenesulfonic acid-induced colitis in rats. Neurogastroenterol Motil 29(6):e13019. https://doi.org/10.1111/nmo.13019 CrossRef

Zizzo MG, Caldara G, Bellanca A, Nuzzo D, Di CM, Serio R (2019) Preventive effects of guanosine on intestinal inflammation in 2, 4-dinitrobenzene sulfonic acid (DNBS)-induced colitis in rats. Inflammopharmacology 27(2):349–359. https://doi.org/10.1007/s10787-018-0506-9 CrossRefPubMed

Titel: PD123319, angiotensin II type II receptor antagonist, inhibits oxidative stress and inflammation in 2, 4-dinitrobenzene sulfonic acid-induced colitis in rat and ameliorates colonic contractility
verfasst von: Maria Grazia Zizzo
Gaetano Caldara
Annalisa Bellanca
Domenico Nuzzo
Marta Di Carlo
Rosa Serio
Publikationsdatum: 18.07.2019
Verlag: Springer International Publishing
Erschienen in: Inflammopharmacology / Ausgabe 1/2020
Print ISSN: 0925-4692
Elektronische ISSN: 1568-5608
DOI: https://doi.org/10.1007/s10787-019-00619-z

Springer Medizin

Abstract

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 1/2020

Betulinic acid attenuates lipopolysaccharide-induced vascular hyporeactivity in the rat aorta by modulating Nrf2 antioxidative function

Anti-inflammatory drugs in the prevention of post-operative atrial fibrillation: a literature review

Polygalasaponin F treats mice with pneumonia induced by influenza virus

Therapeutic potential of aryl hydrocarbon receptor in autoimmunity

Anti-inflammatory effect of bee venom in phthalic anhydride-induced atopic dermatitis animal model

Correction to: Moringa oleifera leaf extracts attenuate Complete Freund’s adjuvant-induced arthritis in Wistar rats via modulation of inflammatory and oxidative stress biomarkers